Medium-sized FLT3 internal tandem duplications confer worse prognosis than short and long duplications in a non-elderly acute myeloid leukemia cohort.
about
Targeted Therapy of FLT3 in Treatment of AML-Current Status and Future Directions.FMS-related tyrosine kinase 3 internal tandem duplication (FLT3-ITD): a villain among others.Risk-stratified therapy for children with FLT3-ITD-positive acute myeloid leukemia: results from the JPLSG AML-05 study.The importance of FLT3 mutational analysis in acute myeloid leukemia.
P2860
Medium-sized FLT3 internal tandem duplications confer worse prognosis than short and long duplications in a non-elderly acute myeloid leukemia cohort.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh-hant
name
Medium-sized FLT3 internal tan ...... acute myeloid leukemia cohort.
@en
Medium-sized FLT3 internal tan ...... acute myeloid leukemia cohort.
@nl
type
label
Medium-sized FLT3 internal tan ...... acute myeloid leukemia cohort.
@en
Medium-sized FLT3 internal tan ...... acute myeloid leukemia cohort.
@nl
prefLabel
Medium-sized FLT3 internal tan ...... acute myeloid leukemia cohort.
@en
Medium-sized FLT3 internal tan ...... acute myeloid leukemia cohort.
@nl
P2093
P2860
P50
P1433
P1476
Medium-sized FLT3 internal tan ...... acute myeloid leukemia cohort
@en
P2093
Andras Bors
Andras Kozma
Andrea Sipos
Arpad Batai
Attila Tordai
Eniko Lehoczky
Hajnalka Andrikovics
Janos Dolgos
Magdalena Koszarska
P2860
P304
P356
10.3109/10428194.2013.850163
P577
2013-11-25T00:00:00Z